J&J and GSK step up Ebola vaccine race

As the WHO opens its third emergency meeting on Ebola, Johnson and Johnson says it's speeding up work on an experimental vaccine against the disease - putting pressure on its main rivals in the vaccine race, GSK and NewLink Genetics, to do the same. Sara Hemrajani reports.

View Transcript


Post Your Comment

Sending ...